Solid Organ Transplant Recipient with Fever and Pulmonary Infiltrates
A 55-year-old kidney transplant recipient on tacrolimus, mycophenolate, and prednisone presents with fever, dry cough, and dyspnea. He is 6 months post-transplant. Chest CT shows bilateral ground-glass opacities. His absolute lymphocyte count is 300/µL. He has no recent travel and no sick contacts. He is hypoxemic with SpO2 88% on room air. Blood cultures are negative. He has not received prophylaxis for Pneumocystis jirovecii because of sulfa allergy. Bronchoalveolar lavage is performed.
1. What is the most likely diagnosis and what initial empiric therapy would you start?
Read the worked answer
The patient is 6 months post-kidney transplant, on immunosuppression, with hypoxemia and bilateral ground-glass opacities. The most likely diagnosis is Pneumocystis jirovecii pneumonia (PJP), especially given lack of prophylaxis due to sulfa allergy. Other possibilities include CMV pneumonitis, community-acquired pneumonia, or other fungal infections. Empiric therapy should cover PJP: trimethoprim-sulfamethoxazole (TMP-SMX) is first-line, but he has a sulfa allergy. However, the allergy history is not specified; if it was a mild reaction, desensitization or cautious use could be considered. Alternatively, pentamidine IV or atovaquone (for mild disease) can be used. Given hypoxemia, I would start pentamidine 4 mg/kg/day IV plus adjunctive corticosteroids (prednisone 40 mg twice daily) because of hypoxemia (PaO2 <70 mmHg). Also, consider CMV treatment with ganciclovir if BAL PCR positive, but empiric not needed. So initial: pentamidine plus steroids, and broad-spectrum antibiotics? Actually, bacterial pneumonia could be covered with ceftriaxone and azithromycin, but PJP is top. I would start TMP-SMX if allergy is not severe; but if severe, use pentamidine. Also, reduce immunosuppression.
2. If BAL returns positive for Pneumocystis jirovecii PCR and the patient has a severe sulfa allergy (anaphylaxis), how would you treat?
Read the worked answer
For severe sulfa allergy, TMP-SMX is contraindicated. Alternatives: pentamidine isethionate 4 mg/kg IV daily for 21 days, or atovaquone 750 mg orally twice daily for mild-moderate disease (but this patient is hypoxemic, so IV pentamidine is preferred). Clindamycin plus primaquine is another option. Pentamidine can cause nephrotoxicity, hypoglycemia, and hypotension. Adjunctive corticosteroids should be continued. Also, consider reducing immunosuppression. If pentamidine is used, monitor renal function and blood glucose.